Meet the team

Elisa Manzotti


Elisa Manzotti

After 12 years of experience in my previous role as Publisher at the Future Science Group, where I launched and managed a portfolio of 50+ journals including the Medline-indexed Regenerative Medicine (Impact Factor 3.52) and Nanomedicine (IF: 5.82), I founded BioInsights with the vision of publishing high-quality research and commentary in areas of bioscience that offer true potential to revolutionize modern healthcare.
Over the years I have developed specialist knowledge in the fields of stem cell research, pharmacogenomics and vaccinology, and have been responsible for the conception, launch and development of several key journal titles that are now widely respected in these areas, including Regenerative Medicine (recipient of the ALPSP ‘Best New Journal’ award in 2006.

Nicola McCall

Head of Business Development

Nicola McCall

Nicola has been working in the life sciences sector for 21 years. She was the Founder & CEO of specialist pharma and biotech conference organiser, Phacilitate, from 2001 to 2012, launching and managing conferences and exhibitions across Europe, North America and Asia.

At BioInsights Nicola works with our clients to deliver content marketing, lead generation and promotional solutions.

Karen Rowland

Editorial Director


Karen is our Editorial Director, working closely with our clients to help better communicate their services and products. She is also our lead designer, developing our distinctive style for all BioInsights publications and websites. Karen specialises in biomedical science design, with over 20 years experience in bio-sciences, starting her career as a pharmaceutical research scientist.
She is also the founder and director of Graphically Ltd, providing biomedical design and illustration services to many clients, ranging from cutting-edge biotech startups to big pharma.

David McCall

Commissioning Editor

David has worked in life sciences publishing and events for 20 years, specialising in cell and gene therapy and immuno-oncology for the majority of that time. His 16 years at Phacilitate from the company’s founding in 2001 saw him take responsibility primarily for content, but also included stints in sales and running the business overall. Having joined BioInsights in 2017, David is now engaged in repurposing a uniquely broad and deep skillset tailored to meet the content generation needs of the global advanced therapy industry and wider community.